The increased incidence of estrogen-receptor-positive (ER+) breast cancer in obesity supports the role for estrogen, a steroid hormone, in breast carcinogenesis (61), bringing the endocrine function of adipose tissue into play. Here, ESR1 is linked to obesity due to melanocortin 4 receptor deficiency.